Alerts will be sent to your verified email
Verify EmailACEMEN
|
ACE Men Engg Works
|
Sunrise Efficient
|
Novelix Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.61 % | 27.13 % | 0.0 |
|
5yr average Equity Multiplier
|
1.29 | 4.36 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.31 | 1.89 | 0.84 |
|
5yr Avg Net Profit Margin
|
0.5 % | 6.21 % | -14.11 % |
|
Price to Book
|
29.69 | 0.0 | 15.84 |
|
P/E
|
0.0 | 12.43 | 62.35 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 125.98 Days | 29.1 Days |
|
Inventory Days
|
0.0 | 47.35 Days | 34.04 Days |
|
Days Receivable
|
0.0 | 94.07 Days | 55.38 Days |
|
Days Payable
|
32.99 Days | 48.56 Days | 55.7 Days |
|
5yr Average Interest Coverage Ratio
|
7.78 | 10.51 | -17.77 |
|
5yr Avg ROCE
|
0.9 % | 39.14 % | -15.4 % |
|
5yr Avg Operating Profit Margin
|
0.85 % | 9.22 % | -16.49 % |
|
5 yr average Debt to Equity
|
0.0 | 1.56 | 0.05 |
|
5yr CAGR Net Profit
|
n/a | 115.15 % | 35.78 % |
|
5yr Average Return on Assets
|
0.38 % | 12.27 % | -13.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.61 % | 41.46 % | 49.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.94 % | -58.54 % | -17.49 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ACE Men Engg Works
|
Sunrise Efficient
|
Novelix Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|